BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

24 hedge funds and large institutions have $11.6M invested in ProShares Ultra NASDAQ Biotechnology in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
7
Closed
7
Calls
$2.54M
Puts
$2.24M
Net Calls
+$303K
Net Calls Change
-$380K

Top Buyers

1
IMC Chicago
1
IMC Chicago
Illinois
$2.4M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$2.15M
3
CIC
3
Chase Investment Counsel
Virginia
$878K
4
JF
4
Jump Financial
Illinois
$627K
5
TCBWMS
5
Texas Capital Bank Wealth Management Services
Texas
$271K

Top Sellers

1
TRCT
1
Tower Research Capital (TRC)
New York
$198K
2
TFA
2
Toth Financial Advisory
Virginia
$493K
3
Jane Street
3
Jane Street
New York
$357K
4
Citadel Advisors
4
Citadel Advisors
Florida
$465K
5
CG
5
Cutler Group
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AWM
26
Activest Wealth Management
Florida
– -$21.1K -365 Closed
DWP
27
Destiny Wealth Partners
Florida
– -$15.6K -270 Closed
IA
28
IFP Advisors
Florida
– -$9K -150 Closed
GRP
29
Global Retirement Partners
California
– -$7.56K -131 Closed
BTI
30
Blue Trust Inc
Georgia
– -$2K -33 Closed
SL
31
Savior LLC
Massachusetts
– -$462 -8 Closed
1
2